ArticleFrontiers in immunology2020

ROS1 Fusion Mediates Immunogenicity by Upregulation of PD-L1 After the Activation of ROS1-SHP2 Signaling Pathway in Non-Small Cell Lung Cancer.

Liangliang Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.